Metraipolis › archive › dc_ebd0536cf4f4

Effect of imeglimin on metabolic dysfunction-associated steatotic liver disease in individuals with type 2 diabetes — Europe PMC PMID:41171838

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41171838
DOI
10.1371/journal.pone.0335888
License (as archived)
solo-consultazione
Archived
2026-11-08T22:20:24.664Z
SHA-256 of the archived text
0c36648a3c87fba70611ff1c8d8f4f88e00863982300df99764cc2eeabc62dd8
Stable URL of this page
https://metraipolis.com/documento/dc_ebd0536cf4f4

How to cite

Effect of imeglimin on metabolic dysfunction-associated steatotic liver disease in individuals with type 2 diabetes — Europe PMC PMID:41171838 — Europe PMC (en), https://europepmc.org/article/MED/41171838 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebd0536cf4f4 (Metraipolis archive dc_ebd0536cf4f4, sha256 0c36648a3c87fba70611ff1c8d8f4f88e00863982300df99764cc2eeabc62dd8)
BibTeX
@misc{dcebd0536cf4f4,
  title = {Effect of imeglimin on metabolic dysfunction-associated steatotic liver disease in individuals with type 2 diabetes — Europe PMC PMID:41171838},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41171838},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebd0536cf4f4; sha256 0c36648a3c87fba70611ff1c8d8f4f88e00863982300df99764cc2eeabc62dd8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41171838. Agents can read the archived copy with the MCP tool read_document.